SAN ANTONIO, May 12, 2026 /PRNewswire/ -- Frost & Sullivan is pleased to announce that Avance Clinical has been awarded the 2026 Global Company of the Year Recognition in the biotechnology contract ...

Faced with growing dominance from China, governments are transforming clinical trial frameworks to boost R&D activity.

As biologics have come to supersede small molecules in the biopharma industry’s pipeline, the mounting complexity behind the ...

SN BioScience Inc., a clinical-stage biotechnology company based in South Korea, announced today that it has initiated the first patient dosing in its global Phase 1b/2 clinical trial evaluating ...

VY1706 IND application process on track for Q2 2026; clinical entry expected H2 2026 -- Data from eight ASGCT presentations ...

Insilico Medicine ('Insilico', 03696.HK), a biotechnology company powered by generative artificial intelligence, today announced that the company has entered a strategic collaboration agreement with ...

Company plans to submit a Biologics License Application (BLA) for aglatimagene besadenovec (aglatimagene or CAN-2409) in localized, intermediate- ...

Cellares, the first Integrated Development and Manufacturing Organization (IDMO), and ProTgen, a biotechnology company ...

Researchers at Mayo Clinic announced on May 15, 2026 that synthetic DNA molecules called aptamers can reliably tag senescent ...

Alto Neuroscience, Inc. (“Alto”) (NYSE: ANRO), a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for neuropsychiatric disorders, today reported ...

The US Food and Drug Administration (FDA) has released a final guidance document with immediate effect advising sponsors on ...